NCT07255950 Accuracy Between Transthoracal Needle Aspiration (TTNA) Techniques in Suspected Lung Cancer Patients
| NCT ID | NCT07255950 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gadjah Mada University |
| Condition | Lung Cancer (Diagnosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2025-07-15 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2025-07-15 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
* The objective of this research is to determine the accuracy of different types of lung transthoracal needle aspiration (TTNA) i.e. jabbing-then-suction, suction-with-jabbing, and suction-only TTNA in patients with suspected lung cancer. * Researchers will compare these techniques to determine whether there are any quality differences in the obtained tumor samples
Eligibility Criteria
Inclusion Criteria: * Patients with suspected lung cancer who will undergo diagnostic testing using ultrasound-guided TTNA of the lung with cell block and core biopsy. * Patients aged 18-75 years. * The tumor is located peripherally, attached to the chest wall. Exclusion Criteria: * Patient refuses lung biopsy * Non-cooperative patient * Patient with respiratory failure, on positive pressure ventilation * Severe pulmonary emphysema * Contralateral pneumonectomy * Advanced pulmonary fibrosis * Platelet count \<100,000/mm3 and international normalized ratio (INR) \>1.4
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07255950 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07255950 currently recruiting?
Yes, NCT07255950 is actively recruiting participants. Contact the research team at roihan.iqbal@gmail.com for enrollment information.
Where is the NCT07255950 trial being conducted?
This trial is being conducted at Yogyakarta, Indonesia.
Who is sponsoring the NCT07255950 clinical trial?
NCT07255950 is sponsored by Gadjah Mada University. The trial plans to enroll 54 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.